Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Friede

Showing results (211-220 of 393) with videos related to

Pageof 40
Sort By:
European Respiratory Review : an Official Journal of the European Respiratory Society|September 4, 2024
Adherence-enhancing interventions for pharmacological and oxygen therapy in patients with COPD: a systematic review and component network meta-analysesOmar Ammous, Regina Kampo, Maximilian Wollsching-Strobel, et al.
European Journal of Heart Failure|April 23, 2024
Randomized investigation of the MitraClip device in heart failure: Design and rationale of the RESHAPE-HF2 trial designStefan D Anker, Tim Friede, Ralph Stephan von Bardeleben, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 23, 2026
Cost-effectiveness of a GLS-based screening and prevention program for pre-heart failure compared to standard of careHannah Kentenich, Sebastian Kelle, Rebecca E Beyer, et al.
Plos One|October 18, 2018
Insights into permanent pacemaker implantation following TAVR in a real-world cohortTobias Tichelbäcker, Leonard Bergau, Miriam Puls, et al.
Trials|February 15, 2021
Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)-study protocol for a randomised controlled trialAnne Christin Rahn, Lisa Wenzel, Andrea Icks, et al.
Trials|March 9, 2021
Correction to: Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)-study protocol for a randomised controlled trialAnne Christin Rahn, Lisa Wenzel, Andrea Icks, et al.
Fortschritte Der Neurologie-Psychiatrie|July 28, 2020
[Multiple sclerosis in Germany: updated analysis of the German MS Registry 2014-2018]Peter Flachenecker, Kerstin Eichstädt, Klaus Berger, et al.
Multiple Sclerosis and Related Disorders|August 11, 2018
Decreasing longitudinal use of glucocorticosteroids in multiple sclerosisDavid Ellenberger, Kerstin Eichstädt, Peter Flachenecker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 20, 2018
Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registryPaulus Stefan Rommer, Kerstin Eichstädt, David Ellenberger, et al.
International Journal of Integrated Care|April 24, 2023
Cost-Effectiveness of Inter-Professional Collaboration to Reduce Hospitalisations in Nursing Home Residents: Results from the German Interprof ACT TrialLouisa-Kristin Muntendorf, Katrin Balzer, Tim Friede, et al.
Pageof 40

Showing results (211-220 of 393) with videos related to

Sort By:
Pageof 40
European Respiratory Review : an Official Journal of the European Respiratory Society|September 4, 2024
Adherence-enhancing interventions for pharmacological and oxygen therapy in patients with COPD: a systematic review and component network meta-analysesOmar Ammous, Regina Kampo, Maximilian Wollsching-Strobel, et al.
European Journal of Heart Failure|April 23, 2024
Randomized investigation of the MitraClip device in heart failure: Design and rationale of the RESHAPE-HF2 trial designStefan D Anker, Tim Friede, Ralph Stephan von Bardeleben, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 23, 2026
Cost-effectiveness of a GLS-based screening and prevention program for pre-heart failure compared to standard of careHannah Kentenich, Sebastian Kelle, Rebecca E Beyer, et al.
Plos One|October 18, 2018
Insights into permanent pacemaker implantation following TAVR in a real-world cohortTobias Tichelbäcker, Leonard Bergau, Miriam Puls, et al.
Trials|February 15, 2021
Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)-study protocol for a randomised controlled trialAnne Christin Rahn, Lisa Wenzel, Andrea Icks, et al.
Trials|March 9, 2021
Correction to: Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)-study protocol for a randomised controlled trialAnne Christin Rahn, Lisa Wenzel, Andrea Icks, et al.
Fortschritte Der Neurologie-Psychiatrie|July 28, 2020
[Multiple sclerosis in Germany: updated analysis of the German MS Registry 2014-2018]Peter Flachenecker, Kerstin Eichstädt, Klaus Berger, et al.
Multiple Sclerosis and Related Disorders|August 11, 2018
Decreasing longitudinal use of glucocorticosteroids in multiple sclerosisDavid Ellenberger, Kerstin Eichstädt, Peter Flachenecker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 20, 2018
Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registryPaulus Stefan Rommer, Kerstin Eichstädt, David Ellenberger, et al.
International Journal of Integrated Care|April 24, 2023
Cost-Effectiveness of Inter-Professional Collaboration to Reduce Hospitalisations in Nursing Home Residents: Results from the German Interprof ACT TrialLouisa-Kristin Muntendorf, Katrin Balzer, Tim Friede, et al.
Pageof 40